About Biologix
Biologix is a company based in Sao Paulo (Brazil) founded in 2015. Platform for remote monitoring of chronic disease patients is provided. Biologix has raised $1.2 million across 1 funding round from investors including Hospital Israelita Albert Einstein and Kortex Ventures. Its website biologix.com.br draws about 20 thousand monthly visits. Biologix offers products and services including Exame do Sono Biologix® and Teste do Ronco Biologix®. Its legal entity is Biologix Sistemas S.A.
Company details
Biologix was founded in 2015 in Sao Paulo, Brazil, within the health technology sector. A digital platform is offered for the remote monitoring of patients with chronic diseases, facilitating data collection and analysis from afar. Operations are based in Brazil, with services centered on improving chronic care management through technology. The platform is accessible via biologix.com.br, supporting healthcare providers in patient oversight.
- Headquarters Sao Paulo, Brazil
- Email••••••••
- Phone•••• ••••
- Website biologix.com.br
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Biologix Sistemas S.A
- Total Equity Funding$1.2M (USD)
in 1 rounds
- Latest Funding Round$1.2M (USD), Seed
May 2024
- InvestorsHospital Israelita Albert Einstein
& 1 more
Products & Services of Biologix
Biologix offers a comprehensive portfolio of products and services, including Exame do Sono Biologix® and Teste do Ronco Biologix®.
Home-based polysomnography is provided for the diagnosis and monitoring of sleep apnea and snoring using smartphones and wireless sensors
An app-integrated test is offered for assessing snoring intensity and duration through a patient's cellphone
Apps and channels of Biologix
its YouTube channel Biologix has 5.59K subscribers and 30 videos.
Videos from Biologix
The most watched videos on Biologix's YouTube channel, Biologix (5.59K subscribers). Click a video to play it here.
More on Biologix.
Funding Insights of Biologix
Biologix has successfully raised a total of $1.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.2 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.2M
- Total Rounds 1
- Last Round Seed — $1.2M
- First Round $1.2M
(May 2024)
- Investors Count 2
All 1 funding rounds of Biologix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $1.2M | Seed | – | Kortex Ventures |
2 investors in total: 2 institutional.
Investors in Biologix
Biologix has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Hospital Israelita Albert Einstein and Kortex Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kortex Ventures is focused on health tech venture capital investments. | kortexventures.com | |||
Multispecialty healthcare services are delivered in Sao Paulo, Brazil. | 1971 | einstein.br | Sao Paulo, Brazil |
Investor details for Biologix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biologix
2 dated milestones of Biologix across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Biologix is founded.
- Funding First funding round of $1.2M.
Web traffic of Biologix
The website of Biologix (biologix.com.br) receives about 19.9K visits a month.
- Monthly visits19.9K
▼ 31.5% vs previous month
Websites whose visitors overlap most with Biologix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| institutodosono.com | 100% | #541,718 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biologix
Biologix was founded in 2015 and raised its 1st funding round 9 years after it was founded.
Biologix is headquartered in Sao Paulo, Brazil.
Biologix is a funded company, having raised a total of $1.2M across 1 funding round to date. The company's 1st funding round was a Seed of $1.2M, raised on May 2024.
Biologix was founded in 2015 in Sao Paulo, Brazil, within the health technology sector. A digital platform is offered for the remote monitoring of patients with chronic diseases, facilitating data collection and analysis from afar. Operations are based in Brazil, with services centered on improving chronic care management through technology. The platform is accessible via biologix.com.br, supporting healthcare providers in patient oversight.
Biologix offers Exame do Sono Biologix® and Teste do Ronco Biologix®.
Biologix has 2 investors. Key investors include Hospital Israelita Albert Einstein, and Kortex Ventures.
Biologix operates through Biologix Sistemas S.A.